Status:
COMPLETED
Paravertebral Block Versus Thoracic Epidural Analgesia
Lead Sponsor:
St. Olavs Hospital
Conditions:
Lung Cancer
Postoperative Pain
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Thoracic epidural analgesia (TEA) is the basic method of analgesia in patients undergoing pulmonary lobectomy. TEA is considered to be a safe and thoroughly investigated method of pain relief that rar...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with lung cancer in stage 1 or 2 who are accepted for VATS-lobectomy
- Exclusion Criteria, preoperative:
- Patients who do not wish to participate
- Patients with:
- suspicion of ingrowth in the thoracic wall.
- marginal lung function.
- kidney failure.
- chronic pains and/ or daily use of opioids.
- cognitive, visual and / or linguistic dysfunction.
- allergies to drugs used in the paravertebral block or the thoracic epidural analgesia.
- Exclusion Criteria, Per- and postoperative
- conversion from VATS to thoractomy.
- unsuccessful admission of thoracic epidural analgesia
- unsuccessful admission of paravertebral block
- postoperative respiratory treatment
- postoperative delirium Patients who for various reasons are not able to self-report pain after surgery.
- Patients who wish to withdraw from the study
Exclusion
Key Trial Info
Start Date :
June 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT04025606
Start Date
June 24 2019
End Date
December 1 2022
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Olavs Hospital
Trondheim, Norway